Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021

Clindamycin and β-lactam antibiotics have been mainstays for treating invasive group A Streptococcus (iGAS) infection, yet such regimens might be limited for strains displaying MLS(B) phenotypes. We investigated 76 iGAS isolates from 66 patients in West Virginia, USA, during 2020–2021. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Lillie M., Choi, Soo Jeon, Chipman, Chloe E., Grund, Megan E., LaSala, P. Rocco, Lukomski, Slawomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124663/
https://www.ncbi.nlm.nih.gov/pubmed/37080963
http://dx.doi.org/10.3201/eid2905.221421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124663/
https://www.ncbi.nlm.nih.gov/pubmed/37080963
http://dx.doi.org/10.3201/eid2905.221421

Ejemplares similares